Prof Buckton can assist with all stages after the discovery of the API, including selection of the best physical form, developing a strategy for preclinical and clinical formulation, stability testing, formulation for oral delivery (including poorly soluble and low dose) and formulation for inhalation.

NCE and generic development.

As well as advice on science and strategy, you can be assisted with outsource partner selection and outsourcer management.